- Home
- TACT vs SLGL Comparison
TACT vs SLGL Comparison
Compare TACT & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- SLGL
- Stock Information
- Founded
- TACT 1996
- SLGL 1997
- Country
- TACT United States
- SLGL Israel
- Employees
- TACT N/A
- SLGL N/A
- Industry
- TACT Computer peripheral equipment
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- SLGL Health Care
- Exchange
- TACT Nasdaq
- SLGL Nasdaq
- Market Cap
- TACT 42.2M
- SLGL 49.4M
- IPO Year
- TACT 1996
- SLGL 2018
- Fundamental
- Price
- TACT $4.46
- SLGL $23.35
- Analyst Decision
- TACT Strong Buy
- SLGL
- Analyst Count
- TACT 1
- SLGL 0
- Target Price
- TACT $5.00
- SLGL N/A
- AVG Volume (30 Days)
- TACT 61.9K
- SLGL 30.8K
- Earning Date
- TACT 08-06-2025
- SLGL 08-15-2025
- Dividend Yield
- TACT N/A
- SLGL N/A
- EPS Growth
- TACT N/A
- SLGL N/A
- EPS
- TACT N/A
- SLGL N/A
- Revenue
- TACT $47,949,000.00
- SLGL $23,931,000.00
- Revenue This Year
- TACT $21.67
- SLGL N/A
- Revenue Next Year
- TACT $7.63
- SLGL $31.17
- P/E Ratio
- TACT N/A
- SLGL N/A
- Revenue Growth
- TACT N/A
- SLGL 264.86
- 52 Week Low
- TACT $3.12
- SLGL $4.01
- 52 Week High
- TACT $4.89
- SLGL $26.89
- Technical
- Relative Strength Index (RSI)
- TACT 64.16
- SLGL 67.94
- Support Level
- TACT $4.09
- SLGL $21.00
- Resistance Level
- TACT $4.51
- SLGL $23.94
- Average True Range (ATR)
- TACT 0.20
- SLGL 2.74
- MACD
- TACT 0.01
- SLGL 0.17
- Stochastic Oscillator
- TACT 59.42
- SLGL 70.73
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.